Whalesbook
Dr. Agarwals Health Care Ltd. Reports Record FY2026 Financials
Total Income (12M FY2026): INR 2,125 Crores | PAT (12M FY2026): INR 168 Crores
Key Takeaways
Dr. Agarwals Health Care achieved its highest-ever revenue in FY2026, exceeding ₹2,000 crore. The company also saw a significant 52.4% increase in profit after tax, reaching ₹168 crore.
Strong Growth Achieved
Dr. Agarwals Health Care Limited announced strong financial results for the fiscal year and fourth quarter ending March 31, 2026. The company marked a major milestone by surpassing ₹2,000 crore in revenue from operations for the first time.
Driving Shareholder Value
This performance highlights the company's solid business momentum and successful expansion efforts. The record revenue and substantial profit growth demonstrate an effective ability to scale operations and manage costs, which is beneficial for shareholders.
Expansion and Surgeries Increase
The company has consistently grown, adding 57 new centers in FY2026 to reach a total of 288 facilities. The number of surgeries performed also saw a healthy increase during the year.
Investor Outlook
Investors can anticipate a continued focus on operational efficiency and further network expansion. The company's results suggest a strong foundation for future growth, potentially leading to increased market share and profitability.
Monitoring Margins
While the financial results are positive, ongoing margin performance will be key to watch, particularly given a slight dip in Q4 PAT margin.
Financial Performance Details
- Full Year FY2026: Total Income grew 20.9% to INR 2,125 Cr. Revenue from Operations increased by 21.6% to INR 2,080 Cr. EBITDA rose 22.2% to INR 614 Cr (28.9% margin), and PAT surged 52.4% to INR 168 Cr (7.9% margin).
- Q4 FY2026: Total Income was up 21.2% to INR 577 Cr. Revenue from Operations increased 22.6% to INR 564 Cr. EBITDA grew 18.9% to INR 174 Cr (30.2% margin), and PAT rose 17.4% to INR 50 Cr (8.7% margin).
- Surgeries: Full year surgeries increased by 14.5%, with Q4 seeing a 23.6% rise.
Future Focus
Moving forward, investors will be watching the company's sustained revenue growth, profitability margins, and the effectiveness of its expanding network of healthcare facilities.